MBOT - Microbot Medical's study of surgical robotic system meets endpoints

Microbot Medical (MBOT) announces the successful completion of an additional feasibility animal study using Liberty Robotic System, the fully disposable surgical robotic system.All the end points of navigating to a clot, crossing the clot, deploying a stent retriever, and manually retrieving an arterial clot in a live pig were met with no intraoperative adverse events.The animal feasibility studies to date, support the Company’s assertion that LIBERTY will potentially allow physicians to safely and easily conduct catheter-based peripheral and neurovascular procedures remotely, avoiding radiation exposure, physical strain and the risk of cross contamination.

For further details see:

Microbot Medical's study of surgical robotic system meets endpoints